#20 Non-Invasive Neurostimulation for Sleep: Neurovalens CEO Jason McKeown

Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribeKey Moments:0:00 Introduction3:23 Initial Interest in Neuroscience/Neurotechnology5:10 Neurovalens: Background, Timeline, Origins7:52 Clinical Trials: Insomnia, Anxiety, Obesity, PTSD, Diabetes 8:40 Neurostimulation: Type and Target10:40 Exploring Various Treatment Types with Neurovalens17:29 Patient Experience20:40 Target Nerves and Brain Regions22:56 Competitors and Differentiators25:32 What is next for Neurovalens?27:34 Commercialization29:55 Patient Education30:39 Refund if it doesn’t work31:53 Wellness Device - Big Learnings and Initial Sales33:40 Early Adopters and Crowdfunding: Indiegogo35:44 Real World Data and FDA Guidance37:17 FDA Involvement in Wellness Space40:23 FDA Confusion Launching Wellness Sleep Product43:01 Advice for Breaking into Neurotech: Students/Young Professionals45:14 The Future of Neurotech (20 years)47:47 Community/Collaboration/ContactRecorded: 2/8/2024Host: Robert Murcko Neurovalens: https://neurovalens.com/

There are no comments yet.

Please log in to write the first comment.